Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› EU
Clinical trial register · European Union · CTIS

EU Clinical Trials Tracker

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2556 most recently authorised of 12777 total CTIS records — a stated recency window, not the full historical archive. Synced 06 Nov 2026, 03:17 UTC
2556
Shown in this register
most recently authorised
12,777
Total on CTIS
full historical archive
789
Phase III
within the shown window
Top member states
Spain 1075 France 930 Germany 898 Italy 778 Poland 619 Netherlands 547

Trials in this register

16 of 2556 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase I
Merck Sharp & Dohme LLC
Nervous System Diseases
Belgium
04/11/2026
Phase I
Merck Sharp & Dohme LLC
Neoplasms
Netherlands
03/11/2026
Phase I
Merck Sharp & Dohme LLC
Cardiovascular Diseases
Belgium
23/10/2026
Phase I
Merck Sharp & Dohme LLC
Immune System Diseases
Belgium
30/09/2026
Phase I
A clinical trial of MK-1824 in healthy participants (MK-1824-002)
2026-527518-22-00Heart failure with preserved ejection fraction
Merck Sharp & Dohme LLC
Cardiovascular Diseases
Belgium
23/09/2026
Phase I
A clinical trial of MK-8210 in healthy participants (MK-8210-001)
2026-527022-13-00HIV-1 (Human Immunodeficiency Virus Type 1)
Merck Sharp & Dohme LLC
Virus Diseases
Belgium
19/08/2026
Phase I
Merck Sharp & Dohme LLC
Parasitic Diseases
Belgium
27/07/2026
Phase I
A clinical trial of MK-1824 in healthy participants (MK-1824-001)
2026-525748-14-00Heart failure with preserved ejection fraction
Merck Sharp & Dohme LLC
Cardiovascular Diseases
Belgium
12/05/2026
Phase I
Merck Sharp & Dohme LLC
Nervous System Diseases
Belgium
06/05/2026
Phase I
Merck Sharp & Dohme LLC
Immune System Diseases
Belgium
13/04/2026
Phase I
A clinical trial of MK-7228 in adults (MK-7228-002)
2025-522147-18-00Atherosclerosis
Merck Sharp & Dohme LLC
Cardiovascular Diseases
Belgium
17/03/2026
Phase I
Merck Sharp & Dohme LLC
Cardiovascular Diseases
Belgium
06/03/2026
Phase I
Merck Sharp & Dohme LLC
Nervous System Diseases
Belgium
02/03/2026
Phase I
A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004)
2025-523412-36-00Systemic lupus erythematosus, Rheumatoid arthritis
Merck Sharp & Dohme LLC
Immune System Diseases
Italy, Belgium, Romania, Spain
02/02/2026
Phase I
A clinical study of MK-6050 in healthy people (MK-6050-001)
2025-523861-58-00Hidradenitis suppurativa
Merck Sharp & Dohme LLC
Immune System Diseases
Belgium
12/11/2025
Phase I
Merck Sharp & Dohme LLC
Nutritional and Metabolic Diseases
Belgium
08/10/2025
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 6 November 2026. https://priyalifescience.com/clinical-trials-europe

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →

About this register

This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,777 trial records at the last sync on 06 Nov 2026, 03:17 UTC; this register shows the 2,556 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.

This page shows the 16 of those trials that match the filters currently applied.

How many clinical trials does CTIS hold?

CTIS held 12,777 trial records at the last sync. Of the 2,556 most recently authorised trials shown in this register, 789 are Phase III, and 16 match the filters currently applied. Trials are counted by authorisation, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.

Summary by phase

Trials by phase, 16 trials
PhaseTrialsShare
Phase I16100%

Most active sponsors

Lead sponsors with the most trials
Lead sponsorTrials
Merck Sharp & Dohme LLC16

Member states with the most trials

Member states by number of trials with a site there
Member stateTrials
Belgium15
Italy1
Netherlands1
Romania1
Spain1

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by member state

Spain (1075) France (930) Germany (898) Italy (778) Poland (619) Netherlands (547) Belgium (455) Czechia (341) Denmark (319) Hungary (254) Greece (237) Austria (219) Romania (219) Bulgaria (218) Sweden (200)
→

Browse trials by condition

Advanced solid tumors (23) Atopic Dermatitis (19) Non-Small Cell Lung Cancer (15) Obesity (14) Parkinson’s disease (14) Multiple sclerosis (13) Rheumatoid arthritis (13) Breast Cancer (11) Ulcerative colitis (11) Prostate Cancer (10)
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.